Last updated: 18 June 2024 at 5:00pm EST

James Collins Net Worth



James Collins biography

Dr. James J. Collins serves as Independent Director of the Company. Dr. Collins has served on our board of directors since January 2017. Dr. Collins has served as the Termeer Professor of Medical Engineering and Science in the Institute for Medical Engineering and Science and the Department of Biological Engineering at MIT since December 2014. Prior to his joining MIT, from October 1990 to November 2014, Dr. Collins served as a professor in biomedical engineering at Boston University. Dr. Collins received a B.S. in Physics from the College of the Holy Cross and a doctorate in Medical Engineering from the University of Oxford. From 1987 to 1990, he was a Rhodes Scholar. Collins’ extensive industry expertise qualifies him to serve on our board of directors.

What is the salary of James Collins?

As the Independent Director of Fulcrum Therapeutics Inc, the total compensation of James Collins at Fulcrum Therapeutics Inc is $113,316. There are 9 executives at Fulcrum Therapeutics Inc getting paid more, with Robert Gould having the highest compensation of $3,889,350.



How old is James Collins?

James Collins is 54, he's been the Independent Director of Fulcrum Therapeutics Inc since 2017. There are 8 older and 5 younger executives at Fulcrum Therapeutics Inc. The oldest executive at Fulcrum Therapeutics Inc is Mark J. Levin, 71, who is the Exec. Chairman.

What's James Collins's mailing address?

James's mailing address filed with the SEC is C/O FULCRUM THERAPEUTICS, INC., 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139.

Insiders trading at Fulcrum Therapeutics Inc

Over the last 5 years, insiders at Fulcrum Therapeutics Inc have traded over $1,450,584 worth of Fulcrum Therapeutics Inc stock and bought 5,263,802 units worth $50,137,344 . The most active insiders traders include Sanofi, Plc Gsk e Capital Management, L.P.Ra .... On average, Fulcrum Therapeutics Inc executives and independent directors trade stock every 30 days with the average trade being worth of $868,035. The most recent stock trade was executed by Alex Sapir on 3 July 2024, trading 150,000 units of FULC stock currently worth $490,500.



What does Fulcrum Therapeutics Inc do?

what if we could regulate genes, not just discover them? what if we could treat disease at their genetic source? what if we could integrate multiple disciplines to develop breakthrough medicines? what if you could be a part of a passionate team committed to the patients we serve? we can. we will. we are. join us. we are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. a fulcrum is defined as the point on which a lever rests, balances and pivots. fulcrum therapeutics is intervening in gene regulatory mechanisms to unlock the information contained in the human genome. the fulcrum product engine is dedicated to bringing balance to the genetic on and off switches in disease. our approach the sequencing of the human genome has provided incredible insight into disease biology, yet the richness of biology comes from the dynamic on and off switches that control the genome – gene regulation. the fulcrum product eng



What does Fulcrum Therapeutics Inc's logo look like?

Fulcrum Therapeutics Inc logo

Fulcrum Therapeutics Inc executives and stock owners

Fulcrum Therapeutics Inc executives and other stock owners filed with the SEC include: